Brunswick director awarded 704 deferred shares
Brunswick Corp director David C. Everitt received a grant of 704 shares of common stock, valued at $79.45 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brunswick Corp director David C. Everitt received a grant of 704 shares of common stock, valued at $79.45 per share. These are deferred shares deposited into his director deferred account and will be automatically distributed in predetermined installments after he ceases serving as a director. Following this award, his beneficial holdings total 38,965 shares, including 241 shares acquired through dividend reinvestments through March 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 704 | $79.45 | $56K |
Footnotes (2)
- F1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
- F2. Beneficial holdings include 241 shares acquired pursuant to dividend reinvestments through March 2026.
Key Figures
Key Terms
director's deferred account financial
Beneficial holdings financial
dividend reinvestments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Brunswick Corp (BC) report for David C. Everitt?
How did dividend reinvestments affect David C. Everitt’s holdings in Brunswick Corp (BC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.